Hepion Pharmaceuticals Announces Postponement of 2021 Annual Meeting of Stockholders

Written by Customer Service on July 23, 2021. Posted in Public Companies.

EDISON, N.J., July 23, 2021 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis (“NASH”), today announced the postponement of its adjourned 2021 Annual Meeting of Stockholders (the “Annual Meeting”) that was to be held on July 23, 2021, at 9:00 a.m. Eastern Time due to a lack of a quorum. The meeting will be rescheduled for a date yet to be determined by the Board of Directors. The Board of Directors will establish a new record date for the Annual Meeting and, based on this record date, the Company will deliver a notice of the new Annual Meeting date to stockholders entitled to receive notice of the Annual Meeting. About Hepion...

Apollo Global Management Announces Date For 2021 Annual Meeting of Stockholders

Written by Customer Service on July 23, 2021. Posted in Public Companies.

NEW YORK, July 23, 2021 (GLOBE NEWSWIRE) — Apollo Global Management, Inc. (NYSE: APO) (the “Company” and together with its consolidated subsidiaries, “Apollo”) announced today that its 2021 Annual Meeting of Stockholders (“Annual Meeting”) will be held on October 1, 2021, at 9:30 a.m., Eastern Daylight Time. The record date for the meeting is August 5, 2021. The Annual Meeting will be held virtually as a result of continuing concerns surrounding the COVID-19 pandemic. Proxy materials will be mailed to stockholders of record on or about August 16, 2021, and will be available on the Securities and Exchange Commission’s website at www.sec.gov and on the Company’s website at www.apollo.com. About Apollo Apollo is a high-growth, global alternative asset manager. We seek to provide our clients excess return at every point...

Transocean Ltd. Announces Second Quarter 2021 Earnings Release Date

Written by Customer Service on July 23, 2021. Posted in Public Companies.

STEINHAUSEN, Switzerland, July 23, 2021 (GLOBE NEWSWIRE) — Transocean Ltd. (NYSE: RIG) announced today that it will report earnings for the second quarter of 2021 after markets close on Monday, August 2, 2021. The company will conduct a teleconference to discuss the results starting at 9 a.m. EDT, 3 p.m. CEST, on Tuesday, August 3, 2021. Individuals who wish to participate should dial +1 313-209-6544 and refer to conference code 1865445 approximately 10 minutes prior to the scheduled start time. The teleconference will be simulcast in a listen-only mode at: www.deepwater.com, by selecting Investors, News, and Webcasts. A replay of the conference call will be available after 12 p.m. EDT, 6 p.m. CEST, on August 3, 2021. The replay, which will be archived for approximately 30 days, can be accessed at +1 719-457-0820, passcode 1865445,...

Emclaire Financial Corp Reports Earnings for Second Quarter 2021

Written by Customer Service on July 23, 2021. Posted in Public Companies.

EMLENTON, Pa., July 23, 2021 (GLOBE NEWSWIRE) — Emclaire Financial Corp (NASDAQ:EMCF), the parent holding company of The Farmers National Bank of Emlenton, reported consolidated net income available to common stockholders of $1.8 million, or $0.67 per diluted common share, for the three months ended June 30, 2021, an increase of $636,000, or 52.9%, from $1.2 million, or $0.44 per diluted common share, reported for the comparable period in 2020. Net income available to common shareholders for the six-month period ended June 30, 2021 was $4.0 million, or $1.46 per diluted common share, an increase of $1.6 million, or 67.7%, from $2.4 million, or $0.88 per diluted common share, for the same period in 2020. The increase in net income for both periods compared to the same periods in 2020 resulted from an increase in net interest income...

Lincoln Electric Announces August 2021 Events With the Financial Community

Written by Customer Service on July 23, 2021. Posted in Public Companies.

CLEVELAND, July 23, 2021 (GLOBE NEWSWIRE) — Lincoln Electric Holdings, Inc., (Nasdaq: LECO) today announced participation in the following upcoming events with the financial community in the month of August: Jefferies Virtual Industrials Conference Wednesday, August 4, 2021 8:30 a.m. Eastern Time Gabriel Bruno, Executive Vice President and Chief Financial Officer The Jefferies Virtual Industrials Conference presentation will be webcast and can be accessed on our Investor Relations web site at https://ir.lincolnelectric.com. A replay will also be available on our web site. Northcoast Research 2021 Industrial and Business Services Conference Monday, August, 9, 2021 Gabriel Bruno, Executive Vice President and Chief Financial Officer Seaport Global Annual Virtual Summer Investor Conference Wednesday, August 25, 2021 Gabriel...

Brooklyn Immuno Reports Inducement Grants

Written by Customer Service on July 23, 2021. Posted in Public Companies.

BROOKLYN, N.Y., July 23, 2021 (GLOBE NEWSWIRE) — Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases, today announced that on July 15, 2021, Jay Sial was granted a non-qualified stock option covering 71,000 shares of Brooklyn’s common stock (the “Time-Based Option”) and a restricted stock unit covering 35,700 shares of Brooklyn’s common stock (the “RSU”). The RSU will vest in four equal installments, with one-fourth of the shares covered by such RSU vesting on the anniversary of the grant date in each of 2022, 2023, 2024 and 2025, in each case for so long as Mr. Sial provides continuous service to Brooklyn through the relevant vesting...

Biogen to Present Data from ADUHELM and Alzheimer’s Disease Portfolio at 2021 Alzheimer’s Association International Conference

Written by Customer Service on July 23, 2021. Posted in Public Companies.

CAMBRIDGE, Mass., July 23, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced it will share multiple oral and poster presentations from its Alzheimer’s disease clinical development portfolio at the Alzheimer’s Association International Conference (AAIC), which will be held in Denver, Colorado and online July 26-30, 2021. The company’s contributions to AAIC will include several presentations highlighting data on ADUHELM™ (aducanumab-avwa) injection 100 mg/mL solution, which was recently granted accelerated approval by the U.S. Food and Drug Administration (FDA) as a treatment for Alzheimer’s disease, as well as its broader Alzheimer’s disease portfolio and research in the field. ADUHELM is indicated for the treatment of Alzheimer’s disease. Treatment with ADUHELM should be initiated in patients with mild cognitive...

Prudential Bancorp, Inc. Announces Third Quarter Fiscal 2021 Results

Written by Customer Service on July 23, 2021. Posted in Public Companies.

PHILADELPHIA, July 23, 2021 (GLOBE NEWSWIRE) — Prudential Bancorp, Inc. (the “Company”) (Nasdaq:PBIP), the holding company for Prudential Bank (the “Bank”), reported net income of $2.2 million, or $0.28 per basic and per diluted share, for the quarter ended June 30, 2021 as compared to $3.6 million, or $0.44 per basic and per diluted share, for the same quarter in fiscal 2020. For the nine months ended June 30, 2021, the Company reported net income of $5.8 million, or $0.73 per basic share and $0.72 per diluted share as compared to $9.0 million, or $1.04 per basic and $1.03 per diluted share, for the same period in fiscal 2020. The 2020 periods included significant gains on sales of investment securities available for sale. Dennis Pollack, President and CEO, commented, “We are pleased to report continued positive operating results....

Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial

Written by Customer Service on July 23, 2021. Posted in Public Companies.

NEW YORK, July 23, 2021 (GLOBE NEWSWIRE) — Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today announced that upon reviewing its investigational new drug (IND) application filed on June 29th, the U.S. Food and Drug Administration (FDA) has requested that Protagenic provide clinical sites with ready-to-inject clinical vials rather than providing site pharmacies with drug substance to be formulated locally. Implementing this FDA guidance will have the added benefit of Protagenic’s control of the formulation of the final drug product. Protagenic is immediately implementing this required change. As a result of this development, the company expects to refile its IND and commence patient enrollment in the 4th quarter of 2021. About...

Arbor Realty Trust Schedules Second Quarter 2021 Earnings Conference Call

Written by Customer Service on July 23, 2021. Posted in Public Companies.

UNIONDALE, N.Y., July 23, 2021 (GLOBE NEWSWIRE) — Arbor Realty Trust, Inc. (NYSE: ABR), today announced that it is scheduled to release second quarter 2021 financial results before the market opens on Friday, July 30, 2021. The Company will host a conference call to review the results at 10:00 a.m. Eastern Time on July 30, 2021. A live webcast and replay of the conference call will be available at http://www.arbor.com in the investor relations section of the Company’s website. Those without web access should access the call telephonically at least ten minutes prior to the conference call. The dial-in numbers are (877) 876-9173 for domestic callers and (785) 424-1669 for international callers. Please use participant passcode ABRQ221 when prompted by the operator. A telephonic replay of the call will be available until August 6,...

Day: July 23, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice